The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis

INTRODUCTION: Treatment-related quality of life (QOL) is an important aspect of diabetes management. Here, we investigated the influence of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on treatment-related QOL in patients with type 2 diabetes mellitus treated with insulin. METHODS: This was a pr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Ther
Auteurs principaux: Mita, Tomoya, Katakami, Naoto, Shiraiwa, Toshihiko, Yoshii, Hidenori, Gosho, Masahiko, Ishii, Hitoshi, Shimomura, Iichiro, Watada, Hirotaka
Format: Artigo
Langue:Inglês
Publié: Springer Healthcare 2017
Sujets:
Brief Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446390/
https://ncbi.nlm.nih.gov/pubmed/28516377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0267-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires